Post-transfusion biotin-labeled red blood cell survival studies in pediatric sickle cell disease with antibodies of uncertain significance.

Autor: Yee MEM; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Zerra PE; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., McCoy JW; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Covington ML; Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Stowell SR; Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Joiner CH; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Lough CM; Medical Services, Lifesouth Community Blood Centers, Gainesville, Florida, USA., Delvadia BB; Transfusion Services, Northside Hospital, Atlanta, Georgia, USA., Josephson CD; Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St. Petersburg, Florida, USA.; Departments of Oncology and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Roback JD; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Fasano RM; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.

Publikováno v: Transfusion [Transfusion] 2024 May; Vol. 64 (5), pp. 800-807. Date of Electronic Publication: 2024 Mar 20.

Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency.

Autor: Honjo K; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA., Russell RM; Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104, USA., Li R; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA., Liu W; Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Stoltz R; Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Tabengwa EM; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA., Hua Y; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA., Prichard L; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA., Kornbrust AN; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA., Sterrett S; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA., Marques MB; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA., Lima JL; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA., Lough CM; LifeSouth Community Blood Centers, Gainesville, FL 32607, USA., McCarty TP; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA., Ketas TJ; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY 10065, USA., Hatziioannou T; Laboratory of Retrovirology, The Rockefeller University, New York, NY 10028, USA., Bieniasz PD; Laboratory of Retrovirology, The Rockefeller University, New York, NY 10028, USA.; Howard Hughes Medical Institute, The Rockefeller University, New York, NY 10028, USA., Redden DT; Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL 35294, USA., Moore JP; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY 10065, USA., Goepfert PA; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.; Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA., Heath SL; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.; Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA., Hahn BH; Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104, USA., Davis RS; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.; Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.; Department of Biochemistry & Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.; Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Publikováno v: Cell reports. Medicine [Cell Rep Med] 2020 Dec 05; Vol. 2 (1), pp. 100164. Date of Electronic Publication: 2020 Dec 05 (Print Publication: 2021).